πŸ‡ΊπŸ‡Έ FDA
Patent

US 10980825

Cyclic dinucleotide

granted A61KA61K31/7076A61K31/7084

Quick answer

US patent 10980825 (Cyclic dinucleotide) held by Takeda Pharmaceutical Company Limited expires Mon Apr 15 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Apr 20 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 15 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/7076, A61K31/7084, A61K47/6807, A61K47/6871